- Forums
- ASX - By Stock
- VR1
- Forbes article
Forbes article, page-38
-
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VR1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.6¢ |
Change
0.003(13.0%) |
Mkt cap ! $33.82M |
Open | High | Low | Value | Volume |
2.5¢ | 2.7¢ | 2.4¢ | $268.8K | 10.75M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 1423432 | 2.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.7¢ | 1493000 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 1373565 | 0.025 |
7 | 4387866 | 0.024 |
5 | 1750434 | 0.023 |
6 | 2441008 | 0.022 |
5 | 2707500 | 0.021 |
Price($) | Vol. | No. |
---|---|---|
0.026 | 528776 | 6 |
0.027 | 1493000 | 6 |
0.028 | 2027500 | 6 |
0.029 | 822589 | 6 |
0.030 | 2284464 | 7 |
Last trade - 14.34pm 12/11/2024 (20 minute delay) ? |
Featured News
VR1 (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online